Rebetol胶囊作为处方用药预计将在今年秋季某些时候在美国得到广泛销售应用。Rebetol是合成核苷酸类似物利巴韦林的一种口服剂型。IntronA是天然存在的α干扰素重组体。目前Rebetol和Intron A联合抗病毒的作用机制还不清楚。Rebetol单独用于治疗慢性丙型肝炎无效。值得注意的是:Rebetol引起的贫血可能会加剧心脏疾病,出现致命 Rebetol capsules are expected to be widely marketed in the United States for sometime this fall as a prescription medication. Rebetol is an oral dosage form of the synthetic nucleotide analog ribavirin. IntronA is a naturally occurring interferon alpha recombinant. At present, the mechanism of the combined antiviral effect of Rebetol and Intron A is unclear. Rebetol used alone for the treatment of chronic hepatitis C is invalid. It is noteworthy that: Anemia caused by Rebetol may aggravate heart disease, fatal